|
|
||||||||
CURRENT COMMENTARIES |
From 1Family Health International, Research Triangle Park, North Carolina.
Intravenous magnesium sulfate tocolysis remains a North American anomaly. This therapy rose to prominence based on poor science and the recommendations of authorities. However, a Cochrane systematic review concluded that magnesium sulfate is ineffective as a tocolytic. The review found no benefit in preventing preterm or very preterm birth. Moreover, the risk of total pediatric mortality was significantly higher for infants exposed to magnesium sulfate (relative risk 2.8; 95% confidence interval 1.26.6). Given its lack of benefit, possible harms, and expense, magnesium sulfate should not be used for tocolysis. Any further use of magnesium sulfate for tocolysis should be restricted to formal clinical trials with approval by an institutional review board and signed informed consent for participants. Should tocolysis be desired, calcium channel blockers, such as nifedipine, seem preferable.
This article has been cited by other articles:
![]() |
F. J. Stanley and C. Crowther Antenatal Magnesium Sulfate for Neuroprotection before Preterm Birth? N. Engl. J. Med., August 28, 2008; 359(9): 962 - 964. [Full Text] [PDF] |
||||
![]() |
M. A. Morgan, R. L. Goldenberg, and J. Schulkin Obstetrician-Gynecologists' Screening and Management of Preterm Birth Obstet. Gynecol., July 1, 2008; 112(1): 35 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Fox, S. E. Gelber, R. B. Kalish, and S. T. Chasen Contemporary Practice Patterns and Beliefs Regarding Tocolysis Among U.S. Maternal-Fetal Medicine Specialists Obstet. Gynecol., July 1, 2008; 112(1): 42 - 47. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Simhan and S. N. Caritis Prevention of Preterm Delivery N. Engl. J. Med., August 2, 2007; 357(5): 477 - 487. [Full Text] [PDF] |
||||
![]() |
D. J. Lyell, K. Pullen, L. Campbell, S. Ching, M. L. Druzin, U. Chitkara, D. Burrs, A. B. Caughey, and Y. Y. El-Sayed Magnesium Sulfate Compared With Nifedipine for Acute Tocolysis of Preterm Labor: A Randomized Controlled Trial Obstet. Gynecol., July 1, 2007; 110(1): 61 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
Oxytocin Receptor Antagonists for Inhibiting Preterm Labour Obstet. Gynecol., July 1, 2007; 110(1): 180 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Burkett, J. M. Gilles, and E. Jacques Magnesium Sulfate Tocolysis: Time to Quit Obstet. Gynecol., March 1, 2007; 109(3): 778 - 778. [Full Text] [PDF] |
||||
![]() |
R. P. Perkins Magnesium Sulfate Tocolysis: Time to Quit Obstet. Gynecol., March 1, 2007; 109(3): 778 - 779. [Full Text] [PDF] |
||||
![]() |
K. Heyborne Magnesium Sulfate Tocolysis: Time to Quit Obstet. Gynecol., February 1, 2007; 109(2): 450 - 450. [Full Text] [PDF] |
||||
![]() |
G. Macones, J. C. Hauth, and C. J. Lockwood Magnesium Sulfate Tocolysis: Time to Quit Obstet. Gynecol., February 1, 2007; 109(2): 450 - 451. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |